Vectura Group plc
Vectura Group plc develops inhaled therapies principally for the treatment of respiratory diseases. Vectura’s main products target diseases such as asthma and chronic obstructive pulmonary disease (COPD), a growing market that is currently estimated to be worth in excess of $25 billion. Vectura seeks to develop certain programmes itself where this will optimise value. Vectura’s formulation and inhalation technologies are available to other pharmaceutical companies on an out-licensing basis where this complements Vectura’s business strategy.
For further information, please visit Vectura’s website at www.vectura.com
| Type: | NORMAL |
| Address: | One Prospect West, Chippenham, Wiltshire, SN14 6FH |
| Website: | www.vectura.com |
| Phone: | +44 (0)1249 667700 |